![Pilot dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram Pilot dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram](https://www.researchgate.net/publication/13691289/figure/fig2/AS:601693326675987@1520466276525/Pilot-dose-ranging-study-demonstrating-the-dose-response-relationship-between-the-dose-of.png)
Pilot dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram
![Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations - Lyauk - 2019 - Clinical and Translational Science - Wiley Online Library Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations - Lyauk - 2019 - Clinical and Translational Science - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/c7a9edc7-742d-402f-9582-01c70cf86768/cts12641-fig-0001-m.jpg)
Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations - Lyauk - 2019 - Clinical and Translational Science - Wiley Online Library
![Multidimensional Phase I Dose Ranging Trials for Stroke Recovery Interventions: Key Challenges and How to Address Them - Emily J. Dalton, Leonid Churilov, Natasha A. Lannin, Dale Corbett, Bruce C. V. Campbell, Multidimensional Phase I Dose Ranging Trials for Stroke Recovery Interventions: Key Challenges and How to Address Them - Emily J. Dalton, Leonid Churilov, Natasha A. Lannin, Dale Corbett, Bruce C. V. Campbell,](https://journals.sagepub.com/cms/10.1177/15459683211019362/asset/images/large/10.1177_15459683211019362-fig4.jpeg)
Multidimensional Phase I Dose Ranging Trials for Stroke Recovery Interventions: Key Challenges and How to Address Them - Emily J. Dalton, Leonid Churilov, Natasha A. Lannin, Dale Corbett, Bruce C. V. Campbell,
![Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies | Respiratory Research | Full Text Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-017-0681-z/MediaObjects/12931_2017_681_Fig2_HTML.gif)
Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies | Respiratory Research | Full Text
![Figure 2, [Design of Dose Range-finding and Prenatal Developmental Toxicity Studies in Rats]. - NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of Vinpocetine (CASRN 42971-09-5) in Sprague Figure 2, [Design of Dose Range-finding and Prenatal Developmental Toxicity Studies in Rats]. - NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of Vinpocetine (CASRN 42971-09-5) in Sprague](https://www.ncbi.nlm.nih.gov/books/NBK559690/bin/DART_03-Image002.jpg)
Figure 2, [Design of Dose Range-finding and Prenatal Developmental Toxicity Studies in Rats]. - NTP Developmental and Reproductive Toxicity Technical Report on the Prenatal Development Studies of Vinpocetine (CASRN 42971-09-5) in Sprague
![Dose-ranging study performed in Gucy2f -/-mice to determine optimal... | Download Scientific Diagram Dose-ranging study performed in Gucy2f -/-mice to determine optimal... | Download Scientific Diagram](https://www.researchgate.net/publication/371231698/figure/fig1/AS:11431281170632069@1687839976955/Dose-ranging-study-performed-in-Gucy2f--mice-to-determine-optimal-dose-of-editing.png)
Dose-ranging study performed in Gucy2f -/-mice to determine optimal... | Download Scientific Diagram
![Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/a238bd50-fef2-4b65-a5c6-f72db5d122a1/psp412196-fig-0001-m.jpg)
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
![Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2162253120300718-gr4.jpg)
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect
![Vaccines | Free Full-Text | Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity Vaccines | Free Full-Text | Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity](https://www.mdpi.com/vaccines/vaccines-10-00756/article_deploy/html/images/vaccines-10-00756-g001.png)
Vaccines | Free Full-Text | Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity
![Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2162253120300718-gr2.jpg)
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect
![Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study - The Lancet Neurology Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study - The Lancet Neurology](https://www.thelancet.com/cms/attachment/097d689b-94cc-46cd-8a41-68b6055e1777/gr1.gif)